ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,613,000 | +3.9% | 34,825 | -45.3% | 0.00% | 0.0% |
| Q1 2019 | $1,553,000 | +183.4% | 63,683 | +65.7% | 0.00% | +100.0% |
| Q4 2018 | $548,000 | +18166.7% | 38,444 | +14191.4% | 0.00% | – |
| Q4 2017 | $3,000 | -66.7% | 269 | -64.9% | 0.00% | – |
| Q3 2017 | $9,000 | +50.0% | 767 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -14.3% | 767 | 0.0% | 0.00% | – |
| Q1 2017 | $7,000 | +16.7% | 767 | -0.4% | 0.00% | – |
| Q4 2016 | $6,000 | +100.0% | 770 | -26.7% | 0.00% | – |
| Q1 2016 | $3,000 | -40.0% | 1,050 | -0.3% | 0.00% | – |
| Q3 2015 | $5,000 | -28.6% | 1,053 | -23.9% | 0.00% | – |
| Q4 2014 | $7,000 | +16.7% | 1,384 | -11.3% | 0.00% | – |
| Q3 2014 | $6,000 | -14.3% | 1,560 | 0.0% | 0.00% | – |
| Q2 2014 | $7,000 | -12.5% | 1,560 | -7.0% | 0.00% | – |
| Q1 2014 | $8,000 | 0.0% | 1,678 | 0.0% | 0.00% | – |
| Q4 2013 | $8,000 | -27.3% | 1,678 | -1.9% | 0.00% | – |
| Q3 2013 | $11,000 | – | 1,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |